NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE252085 Query DataSets for GSE252085
Status Public on Jul 18, 2024
Title The osteocytic actions of glucocorticoids on bone mass, mechanical properties, or perilacunar remodeling outcomes are not rescued by PTH
Organism Mus musculus
Experiment type Expression profiling by array
Summary Glucocorticoids (GC) and parathyroid hormone (PTH) are widely used therapeutic endocrine hormones where their effects on bone and joint arise from actions on multiple skeletal cell types. In osteocytes, GC and PTH exert opposing effects on perilacunar canalicular remodeling (PLR). Suppressed PLR can impair bone quality and joint homeostasis, including in GC-induced osteonecrosis. However, combined effects of GC and PTH on PLR are unknown. Focusing on subchondral bone and joint homeostasis, we hypothesize that PTH, a PLR agonist, could rescue GC-suppressed PLR. The skeletal effects of GC and PTH, alone or combined, were examined in male and female mice by micro-computed tomography, mechanical testing, histology, and gene expression analysis. For each outcome, females were more responsive to GC and PTH than males. GC and PTH exerted regional differences, with GC increasing trabecular bone volume but reducing cortical bone thickness, stiffness, and ultimate force. Despite PTH’s anabolic effects on trabecular bone, it did not rescue GC’s catabolic effects on cortical bone. Likewise, cartilage integrity and subchondral bone apoptosis, alkaline phosphatase activity, and osteocyte lacunocanalicular networks showed no evidence that PTH could offset GC-dependent effects. Rather, GC and PTH each increased cortical bone gene expression implicated in bone resorption by osteoclasts and osteocytes, including Acp5, Mmp13, Atp6v0d2, Ctsk, differences maintained when GC and PTH were combined. Since PTH is insufficient to rescue GC’s effects on young female mouse bone, future studies are needed to determine if osteocyte PLR suppression, due to GC, aging, or other factors, can be offset by a PLR agonist.
 
Overall design Differential expression of humeri bones from male and female mice implanted with placebo or gluococoritoid (prednisolone) pellet and treated with saline or parathyroid hormone 1-34.
Web link https://doi.org/10.3389/fendo.2024.1342938
 
Contributor(s) Yee CS, Kaya S
Citation(s) 39092287
Submission date Dec 26, 2023
Last update date Aug 23, 2024
Contact name Cristal Yee
E-mail(s) cristal.yee@ucsf.edu
Organization name UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Department Orthopaedic Surgery Department
Street address 35 Medical Center Way, 923A
City San Francisco
State/province CA
ZIP/Postal code 94143
Country USA
 
Platforms (1)
GPL34041 SBD_Mouse_2_codeset (94 genes)
Samples (32)
GSM7993461 M_Ctrl_3303
GSM7993462 M_Ctrl_3317
GSM7993463 M_Ctrl_3310
Relations
BioProject PRJNA1057308

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE252085_GC+PTH_Female_NormalizedData_GEO_2023_12_22.xlsx 172.5 Kb (ftp)(http) XLSX
GSE252085_GC+PTH_Males_NormalizedData_GEO_2023_12_22.xlsx 163.8 Kb (ftp)(http) XLSX
GSE252085_RAW.tar 90.0 Kb (http)(custom) TAR (of RCC)

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap